Trial Profile
A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-grade Gliomas
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Ixabepilone (Primary)
- Indications Anaplastic astrocytoma; Glioblastoma; Glioma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 10 Dec 2008 Actual end date added.
- 19 Aug 2005 New trial record.